JP2022541152A5 - - Google Patents
Info
- Publication number
- JP2022541152A5 JP2022541152A5 JP2022501111A JP2022501111A JP2022541152A5 JP 2022541152 A5 JP2022541152 A5 JP 2022541152A5 JP 2022501111 A JP2022501111 A JP 2022501111A JP 2022501111 A JP2022501111 A JP 2022501111A JP 2022541152 A5 JP2022541152 A5 JP 2022541152A5
- Authority
- JP
- Japan
- Prior art keywords
- copper
- composition
- agent
- approximately
- ophthalmic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962873121P | 2019-07-11 | 2019-07-11 | |
| US62/873,121 | 2019-07-11 | ||
| PCT/US2020/041837 WO2021007578A1 (en) | 2019-07-11 | 2020-07-13 | Multi-agent ocular formulations and treatment methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022541152A JP2022541152A (ja) | 2022-09-22 |
| JP2022541152A5 true JP2022541152A5 (https=) | 2023-07-21 |
Family
ID=74115334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022501111A Pending JP2022541152A (ja) | 2019-07-11 | 2020-07-13 | 多形態眼球製剤および治療法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220288114A1 (https=) |
| EP (1) | EP3996644A4 (https=) |
| JP (1) | JP2022541152A (https=) |
| KR (1) | KR20220125210A (https=) |
| CN (1) | CN114364355A (https=) |
| AU (2) | AU2020311441B2 (https=) |
| CA (1) | CA3146848A1 (https=) |
| WO (1) | WO2021007578A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019205774B2 (en) * | 2018-01-05 | 2025-01-02 | University Of Utah Research Foundation | Treatment of myopic progression |
| TW202245810A (zh) * | 2021-02-01 | 2022-12-01 | 美商艾維娜傳送系統公司 | 散光之治療 |
| CN114225016B (zh) * | 2021-12-02 | 2024-07-09 | 北京大学第一医院 | 一种用于抑制近视及圆锥角膜进展的方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04502012A (ja) * | 1989-09-27 | 1992-04-09 | モスコフスキ ナウチノ―イススレドバテルスキ インスティテュト グラツィニフ ボレツネイ イメニ ゲルムゴルツァ | 進行性近視の治療用組成物 |
| AU7488898A (en) * | 1997-05-16 | 1998-12-08 | Corrective Vision, Inc. | Improved contact lens |
| EP1397132A4 (en) * | 2001-05-25 | 2006-12-13 | Valley Forge Pharmaceuticals I | OPHTHALMIC PIRENZEPINE GEL |
| US20060134226A1 (en) * | 2004-11-16 | 2006-06-22 | Todd Leonard | Compositions useful to treat ocular neovascular diseases and macular degeneration |
| WO2012161655A1 (en) * | 2011-05-23 | 2012-11-29 | Singapore Health Services Pte Ltd | Composition and/or method for reducing and/or preventing myopia progression comprising atropine |
| US9421199B2 (en) * | 2014-06-24 | 2016-08-23 | Sydnexis, Inc. | Ophthalmic composition |
| US10010502B2 (en) * | 2015-05-19 | 2018-07-03 | Amorphex Therapeutics Llc | Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation |
| EP3426262B1 (en) * | 2016-03-08 | 2023-08-23 | University of Utah Research Foundation | Cross-linking agents and associated methods |
| US20200345542A1 (en) * | 2017-11-21 | 2020-11-05 | Sydnexis, Inc. | Ophthalmic composition and delivery device thereof |
| AU2019205774B2 (en) * | 2018-01-05 | 2025-01-02 | University Of Utah Research Foundation | Treatment of myopic progression |
-
2020
- 2020-07-13 CN CN202080063471.0A patent/CN114364355A/zh active Pending
- 2020-07-13 EP EP20836819.1A patent/EP3996644A4/en active Pending
- 2020-07-13 WO PCT/US2020/041837 patent/WO2021007578A1/en not_active Ceased
- 2020-07-13 CA CA3146848A patent/CA3146848A1/en active Pending
- 2020-07-13 KR KR1020227004552A patent/KR20220125210A/ko active Pending
- 2020-07-13 US US17/626,469 patent/US20220288114A1/en active Pending
- 2020-07-13 JP JP2022501111A patent/JP2022541152A/ja active Pending
- 2020-07-13 AU AU2020311441A patent/AU2020311441B2/en active Active
-
2026
- 2026-03-04 AU AU2026201640A patent/AU2026201640A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021509902A5 (https=) | ||
| JP2022541152A5 (https=) | ||
| JP2019511493A5 (https=) | ||
| ES2708451T3 (es) | Soluciones de bimatoprost y timolol sin conservantes | |
| WO2014018856A1 (en) | Compositions and treatment for eye diseases and disorders | |
| WO2017115238A1 (en) | Compositions for the treatment of presbyopia | |
| EP2598119A2 (en) | Preservative free brimonidine and timolol solutions | |
| EP2588096A1 (en) | Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease | |
| JP2018528169A (ja) | 眼科用薬物の定量的な眼窩周囲への適用 | |
| EP1187611B1 (en) | Ophthalmic histamine compositions and uses thereof | |
| JP2015523986A (ja) | ラキニモドを使用する眼炎症性疾患の治療 | |
| Bagnis et al. | Antiglaucoma drugs: The role of preservative-free formulations | |
| CN102018656A (zh) | 含有效成分拉坦前列素的眼用凝胶剂及其制备方法 | |
| TWI805705B (zh) | 選擇性syk抑制劑之使用方法及醫藥組合物 | |
| CN103202833A (zh) | 一种奥洛他定或其盐的药用组合物及其制备方法 | |
| WO2025049378A1 (en) | Netarsudil ophthalmological formulations with less toxicity | |
| WO2024211322A2 (en) | Ripasudil based ophthalmic treatments | |
| AU2024298631A1 (en) | Ocular surface topical administration of roflumilast for treatment of anterior and retinal-vitreous chamber ocular diseases | |
| SMIT | Anecortave Acetate for Steroid-Induced OHT | |
| SA06270472B1 (ar) | طريقة لمعالجة النوعين الاولي والثانوي للغلوكوما | |
| HK1210968B (en) | Compositions and treatment for eye diseases and disorders |